Oncolytic herpes simplex virus and radiation combination therapy results in a systemic immune response to inhibit neuroblastoma tumor growth

被引：0
|
作者：
Gillory, Lauren A. [1 ]
Megison, Michael L. [1 ]
Stewart, Jerry E. [1 ]
Nabers, Hugh C. [1 ]
Friedman, Gregory K. [1 ]
Markert, James M. [1 ]
Gillespie, G. Yancey [1 ]
Beierle, Elizabeth A. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2012年 / 215卷 / 03期
关键词：
D O I：
10.1016/j.jamcollsurg.2012.06.192
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [21] Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models
    Zheng, Fei-qun
    Xu, Yin
    Yang, Ren-jie
    Wu, Bin
    Tan, Xiao-hua
    Qin, Yi-de
    Zhang, Qun-wei
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (05) : 617 - 627
  • [22] Oncolytic therapy using a mutant type-1 herpes simplex virus and the role of the immune system - Invited commentary
    Sunday, ME
    ANNALS OF THORACIC SURGERY, 1999, 68 (05): : 1761 - 1762
  • [23] Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment
    Nakamura, Takafumi
    CANCER SCIENCE, 2021, 112 : 579 - 579
  • [24] Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment
    Nakatake, Motomu
    Kuwano, Nozomi
    Kaitsurumaru, Emi
    Kurosaki, Hajime
    Nakamura, Takafumi
    MOLECULAR THERAPY, 2021, 29 (05) : 1782 - 1793
  • [25] Herpes simplex virus mediated oncolysis is an effective intratumoral therapy in high-risk neuroblastoma tumor models
    Parikh, NS
    Currier, MA
    Adams, LC
    Cripe, TP
    PEDIATRIC RESEARCH, 2004, 55 (04) : 285A - 285A
  • [26] Herpes simplex virus mediated oncolysis is an effective intratumoral therapy in high-risk neuroblastoma tumor models
    Parikh, NS
    Currier, MA
    Adams, LC
    Collins, MH
    Cripe, TP
    MOLECULAR THERAPY, 2004, 9 : S112 - S113
  • [27] Oncolytic Herpes Simplex Virus Type 2 Can Effectively Inhibit Colorectal Cancer Liver Metastasis by Modulating the Immune Status in the Tumor Microenvironment and Inducing Specific Antitumor Immunity
    Zhang, Wen
    Zeng, Beibei
    Hu, Xiao
    Zou, Lingjie
    Liang, Jing
    Song, Yan
    Liu, Binlei
    Liu, Shangmei
    HUMAN GENE THERAPY, 2021, 32 (3-4) : 203 - 215
  • [28] Enhanced antitumor efficacy by combining oncolytic herpes simplex virus and Aurora A kinase inhibition in models of neuroblastoma and malignant peripheral nerve sheath tumor
    Currier, Mark
    Rizvi, Tilat
    Nartker, Brooke
    Chen, Duo
    Chen, Chun-Yu
    Wang, Pin-Yi
    Sprague, Les
    Franczek, Meghan
    Patel, Ami
    Chaney, Katherine
    Streby, Keri
    Ecsedy, Jeff
    Conner, Joe
    Ratner, Nancy
    Cripe, Timothy
    CANCER RESEARCH, 2016, 76
  • [29] The effect of the tumor necrosis factor DNA on the immune response in DNA immunization against the herpes simplex virus
    Klimova, RR
    Kozlov, AY
    Shingarova, LN
    Nekrasova, OV
    Boldyreva, EF
    Guseva, TS
    Parshina, OV
    Malinovskaya, VV
    Novikov, VV
    Kushch, AA
    MOLECULAR BIOLOGY, 2004, 38 (02) : 281 - 288
  • [30] The Effect of the Tumor Necrosis Factor DNA on the Immune Response in DNA Immunization against the Herpes Simplex Virus
    R. R. Klimova
    A. Yu. Kozlov
    L. N. Shingarova
    O. V. Nekrasova
    E. F. Boldyreva
    T. S. Guseva
    O. V. Parshina
    V. V. Malinovskaya
    V. V. Novikov
    A. A. Kushch
    Molecular Biology, 2004, 38 : 281 - 288
12345